Insmed (INSM) is a publicly traded Healthcare sector company. As of July 5, 2026, INSM trades at $111.60 with a market cap of $24.19B and a P/E ratio of -19.44. INSM moved +4.30% today. Year to date, INSM is -35.90%; over the trailing twelve months it is +13.60%. Its 52-week range spans $60.40 to $212.75. Analyst consensus is strong buy with an average price target of $199.89. Rallies surfaces INSM's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks politician and congressional stock disclosures for INSM, including purchases, sales, transaction dates, owners, and reported trade amounts when available.
| Metric | Value |
|---|---|
| Price | $111.60 |
| Market Cap | $24.19B |
| P/E Ratio | -19.44 |
| EPS | $-5.74 |
| Dividend Yield | 0.00% |
| 52-Week High | $212.75 |
| 52-Week Low | $60.40 |
| Volume | 0 |
| Avg Volume | 0 |
| Revenue (TTM) | $819.56M |
| Net Income | $-1.18B |
| Gross Margin | 81.81% |
19 analysts cover INSM: 0 strong buy, 19 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $199.89.